President & Portfolio Manager, BVF Partners, LP
Matthew Perry joined BVF Partners L.P. in 1997 and currently serves on the boards on Nordic Biotech Advisors ApS and CTI BioPharma Corp. Prior to joining the General Partner, Matthew held the position of Account Executive with Feinstein Partners, a consulting firm with an emphasis on investor relations for emerging health care companies focused on the development and commercialization of therapeutic products. He was simultaneously an account executive with Feinstein Partners’ affiliate, Kendall Strategies, a business development and strategy consulting firm assisting start-ups through large public biotechnology and pharmaceutical companies. He holds a B.S. from the Biology Department at the College of William and Mary.